Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 23, 2017 08:30 ET | Source: BeyondSpring, Inc.

BeyondSpring Receives Two Grants in China to Further Develop Innovative Drug Pipeline

NEW YORK, Oct. 23, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer...
October 18, 2017 08:30 ET | Source: BeyondSpring, Inc.

BeyondSpring Chief Medical Officer to Present at the 2017 BIO Investor Forum on Oct. 18 in San Francisco

NEW YORK, Oct. 18, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer...
September 05, 2017 16:05 ET | Source: BeyondSpring, Inc.

BeyondSpring to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

NEW YORK, Sept. 05, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a late-stage clinical development company focused on a rich pipeline of innovative immuno-oncology cancer therapies,...
August 21, 2017 07:00 ET | Source: BeyondSpring, Inc.

BeyondSpring Provides Operational Update for Second Quarter of 2017

NEW YORK, Aug. 21, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI) (“BeyondSpring” or the “Company”), a late-stage clinical biopharmaceutical company focusing on the development of a...
August 17, 2017 08:00 ET | Source: BeyondSpring, Inc.

BeyondSpring to Present at the 2017 Southern California Investor Conference

NEW YORK , Aug. 17, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ Capital Markets:BYSI), a late-stage clinical development company focused on a rich pipeline of innovative immuno-oncology...
August 14, 2017 08:00 ET | Source: BeyondSpring, Inc.

BeyondSpring to Host Quarterly Operational Update Conference Call on August 21, 2017

NEW YORK, Aug. 14, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, today...
July 06, 2017 08:00 ET | Source: BeyondSpring, Inc.

China FDA Approves CTAs for BeyondSpring’s Second Global Plinabulin Registrational Trial for Chemotherapy-Induced Neutropenia Prevention

NEW YORK, July 06, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative immuno-oncology cancer...
June 15, 2017 09:03 ET | Source: BeyondSpring, Inc.

BeyondSpring Chief Medical Officer to Present Clinical Data for Lead Asset Plinabulin at 2017 BIO International Convention in San Diego

NEW YORK, June 15, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, announced...
June 02, 2017 16:32 ET | Source: BeyondSpring, Inc.

BeyondSpring to Present at the Jefferies 2017 Healthcare Conference

NEW YORK, June 02, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a late-stage clinical development company focused on a rich pipeline of innovative immuno-oncology cancer therapies,...
June 01, 2017 16:15 ET | Source: BeyondSpring, Inc.

BeyondSpring to Attend Jefferies 2017 Healthcare Conference

NEW YORK, June 01, 2017 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a late-stage clinical development company focused on a rich pipeline of innovative immuno-oncology cancer therapies,...